• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Salix Pharmaceuticals, Ltd. (SLXP)

    -NasdaqGS
    172.81 0.00(0.00%) Mar 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:172.81
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:161.11
    Beta:0.66
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:86.00 - 172.98
    Volume:0
    Avg Vol (3m):4,057,860
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-6.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SLXP 0.00%N/A
    BAYRYDown 3.16%N/A
    GSKDown 0.66%109.30B
    WCRX 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (Mar-15) :N/A
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback